For example, mutations in genes involved in IGF (insulin-like growth factor) signalling, including the IGF1 receptor (IGF1R), were identified in around 7–14% of osteosarcomas, with many of these genes having altered activity compared with normal human osteoblasts or mesenchymal stem cells [36, 63]. Here, IGF1R is linked to osteosarcoma.